Work

Impact of race/ethnicity, donor and recipient age, and donor on survival after allogeneic transplant in the post-transplant cyclophosphamide era

Year: 2026
Type: article
Abstract: Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative treatment for hematologic malignancies, and outcomes have improved over time [ 1 ]. However, Hispanic and non-Hispanic Black (NHB) patients have worse overall survival (OS) compared to non-Hispanic White (NHW) patients and are less likely to utilize an unrelated HCT donor [ 2 , 3 ], but this difference has not been evaluated in the post-transplant cyclophosphamide (PTCy) era. PTCy reduces GvHD and allows for increased availability of alternative allogeneic donors in minority patients [ 4 ].
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: gold
Estimated APC paid: $5,290
OpenAlex ID: W7235294396
FWCI:
Cites: 10
Cited by:
Related to: 10